About Breathe Life Sciences
Breathe Life Sciences is a Consumer company based in London (United Kingdom) founded in 2021 by Samuel Watson, and was acquired by Bioxyne in July 2023. Brand of cannabis medical, health, and wellness products. Its chief executive, as recorded, is Samuel Watson. Breathe Life Sciences offers products and services including CBD Isolate, Full Spectrum CBD Oil, CBG Isolate, CBD Broad Spectrum Distillate, and Transdermal CBD Patches. Its focus areas include Retail, Cannabis Brands and Retailers, Brands and Application Specific. Its competitors include CiiTECH, Theros Pharmaceutical and Diem Botanics; 1 of its 3 listed competitors has raised funding.
Company details
Breathe Life Sciences brand of cannabis medical, health, and wellness products, focusing on engaging in retail operations, cannabis brands and retailers, brands, application specific, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters London, United Kingdom
- Founders Samuel Watson
- Stage Acquired
- SectorsConsumer
- Email••••••••
- Website breathelifesciences.com
- Social LinkedIn
- Acquired by Bioxyne (Jul 2023)
Products & Services of Breathe Life Sciences
Breathe Life Sciences offers a comprehensive portfolio of products and services, including CBD Isolate, Full Spectrum CBD Oil, CBG Isolate, CBD Broad Spectrum Distillate, and Transdermal CBD Patches.
Pure CBD compound used in health and cosmetic formulations.
Oil with multiple cannabinoids for wellness applications.
CBG compound for natural health product development.
Distillate without THC for safe consumer use.
Patches for targeted CBD delivery in skincare.
Capsules containing CBD for daily health intake.
Custom product creation using cannabinoids and ingredients.
Investors in Breathe Life Sciences
Breathe Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Bioxyne.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Probiotic-based dietary supplements for immune health are developed. | 1997 | bioxyne.com | Sydney, Australia |
Investor details for Breathe Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Breathe Life Sciences
1 people are tracked at Breathe Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Samuel Watson | Founder & CEO | Leadership |
Complete people profiles for Breathe Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Breathe Life Sciences
2 dated milestones of Breathe Life Sciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Breathe Life Sciences is founded.
- Exit Acquired by Bioxyne.
Competitors of Breathe Life Sciences
Breathe Life Sciences has 3 listed competitors in our database, 1 of them funded. They include CiiTECH, Theros Pharmaceutical and Diem Botanics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ciitech.co.il | 2017 | London, United Kingdom | $2.91M | Cannabis therapeutics for neurological disorders and others are developed. | ||
| theros.co | 2012 | Newcastle Upon Tyne, United Kingdom | Medical cannabis products are developed and branded by Theros Pharmaceutical. | |||
| diembotanics.co.uk | 2019 | London, United Kingdom | Delivers cannabis-based wellness products to enhance health and well-being. |
Detailed competitors of Breathe Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Breathe Life Sciences
The website of Breathe Life Sciences (breathelifesciences.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 142% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Breathe Life Sciences
Breathe Life Sciences was founded in 2021.
Breathe Life Sciences is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Samuel Watson is the CEO of Breathe Life Sciences, as recorded in our data. They have also founded this company.
Breathe Life Sciences brand of cannabis medical, health, and wellness products, focusing on engaging in retail operations, cannabis brands and retailers, brands, application specific, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Breathe Life Sciences's top competitors include CiiTECH, Theros Pharmaceutical and Diem Botanics.
Breathe Life Sciences offers CBD Isolate, Full Spectrum CBD Oil, CBG Isolate, CBD Broad Spectrum Distillate, and 3 more products and services.
Breathe Life Sciences has 1 investor. Key investors include Bioxyne.
Yes. Breathe Life Sciences was acquired by Bioxyne in July 2023.